REQUEST A DEMO
Total
USD $0.00
Search more companies

Laxter-Pharmacia Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Laxter-Pharmacia Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Laxter-Pharmacia Bt. is based in Hungary, with the head office in Dunakiliti. It operates in the Pharmacies and Drug Stores industry. Laxter-Pharmacia Bt. was incorporated on August 06, 1996. Laxter-Pharmacia Bt. currently employs 1 (2017) people. From the latest financial highlights, Laxter-Pharmacia Bt. reported a net sales revenue increase of 14.38% in 2023. During that time, Laxter-Pharmacia Bt.’s total assets grew by 8.22%. In 2023, Laxter-Pharmacia Bt.’s net profit margin increased by 2.06%.

Headquarters
Kossuth L. u. 96/A.
Dunakiliti; Gyor-Moson-Sopron; Postal Code: 9225

Contact Details: Purchase the Laxter-Pharmacia Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Laxter-Pharmacia Bt. report to view the information.
Outstanding Shares:
Purchase the Laxter-Pharmacia Bt. report to view the information.
Registered Capital:
Purchase the Laxter-Pharmacia Bt. report to view the information.
Incorporation Date:
August 06, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Laxter-Pharmacia Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
14.38%
Total operating revenue
14.1%
Operating profit (EBIT)
104.07%
EBITDA
43.69%
Net Profit (Loss) for the Period
130.98%
Total assets
8.22%
Total equity
148.99%
Operating Profit Margin (ROS)
1.86%
Net Profit Margin
2.06%
Return on Equity (ROE)
-4.66%
Quick Ratio
0.33%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?